Uscom Limited (ASX:UCM)

Practice changing, non-invasive cardiovascular and pulmonary devices.

Follow company

About Us

Uscom has a mission to demonstrate leadership in science and create non-invasive devices that assist clinicians improve clinical care and patient outcomes. Uscom has three practice changing suites of devices in the field of cardiac, vascular and pulmonary monitoring; the USCOM 1A advanced hemodynamic monitor, Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic Suite of digital multi-path ultrasonic spirometers.

Latest News

These ASX stocks are set to ride China’s market wave as trade relations warm

26th July 2024

Check up: Coronavirus has been good and bad for the bio-stocks

5th February 2020

Company Overview

Headquartered in Sydney, Australia, Uscom Limited has been at the forefront of medical technology innovation. The company's flagship product, the USCOM 1A, is a non-invasive hemodynamic monitor that measures cardiovascular function using Doppler ultrasound, aiding in the detection of irregularities and guiding treatment. This device is widely used in emergency departments, intensive care units, and anesthesia.

In addition to the USCOM 1A, the company offers the Uscom BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and waveforms at the heart and arm, providing critical information previously obtainable only through invasive methods. The Uscom SpiroSonic line comprises digital ultrasonic spirometers designed for precise pulmonary function testing, essential in diagnosing and managing respiratory conditions.

Board & Management

Rob Phillips

Chairman and Executive Director

Rob Phillips is the founder of Uscom Ltd, and the Chief Executive Officer, Chairman and Chief Scientist of the Company. Rob has 20 years experience in corporate management since taking Uscom public in 2003, and has taken the company global with regional head quarters in Singapore, Beijing and Budapest with offices in Delawere. Rob has a PhD and MPhil in Cardiovascular Medicine from The University of Queensland where he is an Adjunct Associate Professor of Medicine.

Christian Bernecker

Non-executive Director

Mr Christian Bernecker is a Non-Executive Director of Uscom Ltd since November 2011. Christian has more than 10 years of broad investment experience across capital raising, acquisitions and divestments. Christian qualified as a Chartered Accountant in Australia and holds a Bachelor of Commerce from Ballarat University.

Brett Crowley

Non-executive Director and Company Secretary

Brett Crowley was appointed as a Non-Executive Director of Uscom Ltd on 23 August 2018. He is a practicing solicitor and a former Partner of Ernst & Young in Hong Kong and Australia, and of KPMG in Hong Kong, and has worked in China establishing and managing JV companies there. Mr Crowley is an experienced chairman, finance director and company secretary of ASX-listed companies, and is a former Senior Legal Member of the NSW Civil and Administrative Tribunal.

Xianhui Meng